Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2015 Nov 17;19(1):72–78. doi: 10.1038/pcan.2015.53

Table 3.

Proportion of Patients Achieving a >50% PSA Response, According to Prior Abiraterone or Ketoconazole Use.

All Patients (n = 200) Docetaxel Alone (n = 69) Docetaxel + Prednisone (n = 131) P-value
No Prior Abi/Keto (n = 89) 49 / 89 (55%) 14 / 35 (40%) 35 / 54 (65%) 0.03
Prior Abi/Keto (n = 111) 62 / 111 (56%) 19 / 34 (56%) 43 / 77 (56%) >0.99

P-values are based on Fisher’s Exact test.